Since BACE-1 plays a major role in the initiation of neuropathological cascade of plaque formation and AChE accelerates Aβ deposition in brain, both of these enzymes hold considerable promise as therapeutic targets of AD. Here, BACE1 is linked to Alzheimer disease.